Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
20/20 BioLabs Announces Exclusive U.S. License Agreement with ROKIT Healthcare
-
Yatiri Bio is a precision medicine company focused on identifying and validating biomarkers that predict therapeutic response in oncology.
-
AI-powered autonomous research agents to be deployed in support of PEX010 clinical development strategy, leveraging Kala Bio’s purpose-built agentic AI platform for the biotechnology industry TORONTO...
-
Australia's only viral vector CDMO, Viral Vector Manufacturing Facility Pty Ltd (VVMF), enters into a licensing and option agreement with OXB (LSE:OXB).
-
FDA Grants $4.3 Million Small Business Waiver, Enabling Focus on Commercialization Preparations Company On Track to Initiate NDA Submission by the End of this Month PETACH TIKVA, Israel, March 17,...
-
1606 Corp. Signs Agreement to Acquire Data-Center-Ready Property with Captive Power on 132 Acres
-
BOSTON, March 16, 2026 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with rare...
-
KOMO Biosciences announced that it has granted Syngenta , a Research Evaluation License to assess aspects of KOMO’s proprietary KOMbine™ platform.
-
Adeia and UMC Expand Long-Term Collaboration in Hybrid Bonding Technologies
-
Islamabad, Dubai and New York - March 10, 2026: VEON Ltd. (Nasdaq: VEON, “VEON”), a global digital operator, is pleased to note the successful mobile spectrum auction held today in its largest market...